- NEWS AND VIEWS
Bioengineered ‘mini-colons’ shed light on cancer progression
Access options
Nature 629, 292-293 (2024)
doi: https://doi.org/10.1038/d41586-024-01018-3
References
Lorenzo-Martín, L. F. et al. Nature 629, 450–457 (2024).
Hanahan, D. & Weinberg, R. A. Cell 144, 646–674 (2011).
Clevers, H. Cell 165, 1586–1597 (2016).
Nikolaev, M. et al. Nature 585, 574–578 (2020).
Drost, J. et al. Nature 521, 43–47 (2015).
Barker, N. et al. Nature 457, 608–611 (2009).
Kozar, S. et al. Cell Stem Cell 13, 626–633 (2013).
Nicholson, A. M. et al. Cell Stem Cell 22, 909–918 (2018).
Competing Interests
N.R. is employed by Genentech, Inc. and owns shares of Roche. F.d.S.e.M. is an employee of Amgen and owns shares of Roche and Amgen.